About 1 result found for searched term "Vudalimab" (0.224 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25080 | Vudalimab | PD-1/PD-L1 |
| Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
